Skip to main navigation Skip to search Skip to main content

First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector

for the IPCAVD006/RV380/HIV-V-A002 Study Group

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology